The Hammer Neuromodulation Lab focuses on developing novel neuromodulation therapies for movement disorders such as Parkinson's disease, essential tremor, cerebellar ataxia, and dystonia. The lab aims to understand the neurophysiology of these disorders to enhance current treatments like deep brain stimulation (DBS) and to develop new technologies. It is part of Penn's Center for Neuroengineering & Therapeutics, which emphasizes brain science, translation, innovation, and modulation. The lab collaborates across engineering and medicine to advance therapies for movement disorders.